Vicks Inhaler

Source: 1. Stamos E. Nasal Decongestant Study: Vick Rhinorheometer. CRD 71-1. Laurelton Research Institute 1971. 2. P&G internal studies 1997081, 1997082 (1998, 1999). 3. Martindale, The Complete Drug Reference, 35th Edition, page:1414. S0 VICKS VAPORUBN. Reg.No.:34/10.2.1/0019 (Act 101/1965). Each gram contains: Menthol 28,2 mg, Camphor 52,6 mg, Eucalyptus Oil 13,3 mg. Classification: A10.2.1 Inhalants. S1 VICKS SINEX DECONGESTANT NASAL SPRAY. Reg. No.: 33/16.1/0339 (Act 101/1965). Each 15,0 ml Solution Contains: Oxymetazoline Hydrochloride 7,5 mg, Preservatives: Benzalkonium Chloride 0,02 % m/v, Chlorhexidine Gluconate 0,054 % m/v. Reg. No.: 33/16.1/0339 (Act 101/1965). Classification: A16.1 Nasal Spray Solution. S0 VICKS HONEY & GINGER COUGH SYRUP. Reg. No.: 34/10.1/0017 (Act 101/1965) Each 15,0 ml Syrup Contains: Guaifenesin 200 mg, Preservatives: Sodium Benzoate 0,1 % m/v Contains alcohol & sugar. Reg. No.: 34/10.1/0017 (Act 101/1965) Classification: A10.1 Antitussives and expectorants. S0 VICKS ACTA PLUS COUGH SYRUP. Reg. No.: F/10.1/75 (Act 101/1965).Each 10 ml Syrup Contains: Pentoxyverine Citrate 15 mg, Glyceryl Guaiacolate 100 mg, Cetylpyridinium Chloride 2.5 mg, Preservative: Sodium Benzoate 0,1 % m/v Contains alcohol & sugar.. Classification: A10.1 Antitussives and expectorants. S0 VICKS INHALER. Reg.No.: G1258 (Act 101/1965) Each 1,0 ml medication for nasal use contains: Levomenthol 415,4 mg, Camphor 415,4 mg, Contains Methyl Salicylate. Classification: A10.2.1 Inhalants. PROCTER & GAMBLE SA TRADING (PTY) LTD, Co. Reg. No.: 1989/004241/07, 15 Alice Lane Towers, Alice Lane, Sandton, Tel: +27 10 001 9650, - APG/001/11/16, FOR FULL PRESCRIBING INFORMATION REFER TO THE PACKAGE INSERT APPROVED BY MCC.

Always read the label. Use only as directed. If symptoms persist, see your healthcare professional.